- Country: Japan
- Summary: Liquefied Oxygen (Japanese Extra-Pharmacopoeia Pharmaceutical, Purity 99.5% or More)
- JPT Ref No: 116494066
- Deadline: 03 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Liquefied oxygen (Japanese Extra Pharmacopoeia, purity of 99.5% or more)
Description: Liquefied oxygen (Japanese Extra Pharmacopoeia, purity of 99.5% or more)
Bill Publication The National University Corporation of Ryukyu will be submitted to a general competitive bid for the purchase of liquefied oxygen (Japanese Extra Pharmacopoeia, purity of 99.5% or more) as follows.
Note...
Deadline: 2025-04-03
[Disclaimer: No specific deadline is specified for this notification, so 15 days have been added from the posting date] - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLiquefied Oxygen (Japanese Extra-Pharmacopoeia Pharmaceutical, Purity 99.5% or More) - Japan Tender
The UNIVERSITY OF THE RYUKYUS NATIONAL UNIVERSITY CORPORATION, a Government sector organization in Japan, has announced a new tender for Liquefied Oxygen (Japanese Extra-Pharmacopoeia Pharmaceutical, Purity 99.5% or More). This tender is published on JapanTenders under JPT Ref No: 116494066 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-03.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
